Author:
Valiulin Sergey V.,Onischuk Andrey A.,Dubtsov Sergey N.,Baklanov Anatoly M.,An'kov Sergey V.,Plokhotnichenko Maria E.,Tolstikova Tatyana G.,Dultseva Galina G.,Rusinov Vladimir L.,Charushin Valery N.,Fomin Vasily M.
Funder
Russian Science Foundation
Reference27 articles.
1. Ongoing clinical trials for the management of the COVID-19 pandemic;Lythgoe;Trends Pharmacol Sci,2020
2. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread;Vincent;Virol J,2005
3. A new antiviral drug Triazavirin: results of phase II clinical trial;Kiselev;Vopr Virusol,2012
4. Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure;Shvetsov;J Biomol Struct Dyn,2018
5. New antiviral drug Triazavirin. Results of phase 1 clinical trial;Deeva;Epidemiol Infect Dis,2013
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献